VEGF gene polymorphism association with diabetic neuropathy

Molecular Biology Reports

Volumn 37, Issue 7, 2010, Pages 3625-3630

  Tavakkoly Bazzaz, Javad ^a,b   Amoli, Mahsa M ^a   Pravica, Vera ^c   Chandrasecaran, Ramesh ^d   Boulton, Andrew J M ^d   Larijani, Bagher ^a   Hutchinson, Ian V ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Diabetic neuropathy; Polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN LOCALIZATION;

DIABETIC NEUROPATHIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956963446     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0013-6     Document Type: Article

References (47)

1. P Vague O Brunetti AM Valet I Attali V Lassmann-Vague B Vialettes 1988 Increased prevalence of neurologic complications among insulin dependent diabetic patients of Algerian origin Diabetes Metab 14 706 711 1:STN:280:DyaL1M3jt1ejsg%3D%3D
2. P Vague O Dufayet T Coste C Moriscot MF Jannot D Raccah 1997 Association of diabetic neuropathy with Na/K ATPase gene polymorphism Diabetologia 40 506 511 1:CAS:528:DyaK2sXjtVOrsb8%3D 10.1007/s001250050708 9165217
3. P Vague O Dufayet MF Lamotte C Mouchot D Raccah 1997 Genetic factors, Na K ATPase activity and neuropathy in diabetics Bull Acad Natl Med (French) 181 1811 1821 1:CAS:528:DyaK1cXksFWnsbk%3D
4. AE Heesom A Millward AG Demaine 1998 Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene J Neurol Neurosurg Psychiatry 64 213 216 1:STN:280:DyaK1c7kvFWktQ%3D%3D 10.1136/jnnp.64.2.213 9489533
5. EL Feldman MJ Stevens PK Thomas MB Brown N Canal DA Greene 1994 A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1281 1289 1:STN:280:DyaK2M7itFWmtw%3D%3D 10.2337/diacare.17.11.1281 7821168
6. LP Aiello JS Wong 2000 Role of vascular endothelial growth factor in diabetic vascular complications Kidney Int Suppl 77 S113 S119 1:CAS:528:DC%2BD3cXms1Oiu7k%3D 10.1046/j.1523-1755.2000.07718.x 10997700
7. RB Caldwell M Bartoli MA Behzadian AE El-Remessy M Al-Shabrawey DH Platt RW Caldwell 2003 Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives Diabetes Metab Res Rev 19 442 455 1:CAS:528:DC%2BD2cXis1yqug%3D%3D 10.1002/dmrr.415 14648803
8. M Khamaisi BF Schrijvers AS De Vriese I Raz A Flyvbjerg 2003 The emerging role of VEGF in diabetic kidney disease Nephrol Dial Transplant 18 1427 1430 1:CAS:528:DC%2BD3sXmtFKqs7w%3D 10.1093/ndt/gfg242 12897074
9. GM Leinninger AM Vincent EL Feldman 2004 The role of growth factors in diabetic peripheral neuropathy J Peripher Nerv Syst 9 26 53 1:CAS:528: DC%2BD2cXisFyqsrc%3D 10.1111/j.1085-9489.2004.09105.x 14871451
10. P Schratzberger DH Walter K Rittig FH Bahlmann R Pola C Curry M Silver JG Krainin DH Weinberg AH Ropper JM Isner 2001 Reversal of experimental diabetic neuropathy by VEGF gene transfer J Clin Invest 107 1083 1092 1:CAS:528:DC%2BD3MXjsVCjtLc%3D 10.1172/JCI12188 11342572
11. SA Price C Dent B Duran-Jimenez Y Liang L Zhang EJ Rebar CC Case PD Gregory TJ Martin SK Spratt DR Tomlinson 2006 Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy Diabetes 55 1847 1854 1:CAS:528: DC%2BD28XlsF2qsrw%3D 10.2337/db05-1060 16731852
12. KL Jin XO Mao DA Greenberg 2000 Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc Natl Acad Sci USA 97 10242 10247 1:CAS:528:DC%2BD3cXmtleht7c%3D 10.1073/pnas.97.18.10242 10963684
13. E Duh LP Aiello 1999 Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox Diabetes 48 1899 1906 1:CAS:528: DyaK1MXmsVequ7c%3D 10.2337/diabetes.48.10.1899 10512352
14. RG Tilton T Kawamura KC Chang Y Ido RJ Bjercke CC Stephan TA Brock JR Williamson 1997 Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor J Clin Invest 99 2192 2202 1:CAS:528:DyaK2sXjtFCitr8%3D 10.1172/JCI119392 9151791
15. RG Tilton 2002 Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF Microsc Res Tech 57 390 407 1:CAS:528: DC%2BD38Xlt1Crt7s%3D 10.1002/jemt.10092 12112445
16. Y Ido KC Chang WS Lejeune RJ Bjercke KM Reiser JR Williamson RG Tilton 2001 Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C Microcirculation 8 251 263 1:CAS:528:DC%2BD3MXmvV2ru7c%3D 11528533
17. ME Cooper 2001 Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy Diabetologia 44 1957 1972 1:CAS:528:DC%2BD38XisFGmsQ%3D%3D 10.1007/s001250100000 11719827
18. LP Aiello JM Northrup BA Keyt H Takagi MA Iwamoto 1995 Hypoxic regulation of vascular endothelial growth factor in retinal cells Arch Ophthalmol 113 1538 1544 1:CAS:528:DyaK28XmslOrsw%3D%3D 7487623
19. R Natarajan W Bai L Lanting N Gonzales J Nadler 1997 Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells Am J PhysioI 273 H2224 H2231 1:CAS:528:DyaK2sXnsVGis7g%3D
20. T Murata R Nagai T Ishibashi H Inomuta K Ikeda S Horiuchi 1997 The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas Diabetologia 40 764 769 1:CAS:528:DyaK2sXksFemsr4%3D 10.1007/s001250050747 9243096
21. C Treins S Giorgetti-Peraldi J Murdaca E Van Obberghen 2001 Regulation of vascular endothelial growth factor expression by advanced glycation end products J Biol Chem 276 43836 43841 1:STN:280:DC%2BD3MnmslKhuw%3D%3D 10.1074/jbc.M106534200 11571295
22. B Williams B Gallacher H Patel C Orme 1997 Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro Diabetes 46 1497 1503 1:CAS:528:DyaK2sXlvFenu7k%3D 10.2337/diabetes.46.9.1497 9287052
23. RB Caldwell M Bartoli MA Behzadian AE El-Remessy M Al-Shabrawey DH Platt GI Liou RW Caldwell 2005 Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress Curr Drug Targets 6 511 524 1:CAS:528:DC%2BD2MXlslChtbs%3D 10.2174/1389450054021981 16026270
24. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581 611 1:CAS:528:DC%2BD2cXns1Ght74%3D 10.1210/er.2003-0027 15294883
25. HF Dvorak LF Brown M Detmar AM Dvorak 1995 Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1029 1039 1:CAS:528:DyaK2MXmt1Kkt7g%3D 7538264
26. DA Antonetti AJ Barber S Khin E Lieth JM Tarbell TW Gardner 1998 Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group Diabetes 47 1953 1959 1:CAS:528:DyaK1cXnvVCru7Y%3D 10.2337/diabetes.47.12.1953 9836530
27. EN Unemori N Ferrara EA Bauer EP Amento 1992 Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells J Cell Physiol 153 557 562 1:CAS:528:DyaK3sXhs12msA%3D%3D 10.1002/jcp.1041530317 1447317
28. N Ferrara K Carver-Moore H Chen M Dowd L Lu KS O'Shea L Powell-Braxton KJ Hillan MW Moore 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 439 442 1:CAS:528:DyaK28XitVKqtLk%3D 10.1038/380439a0 8602242
29. H Mu XM Zhang JJ Liu L Dong ZL Feng 2009 Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells Mol Biol Rep 36 8 2147 2151 1:CAS:528:DC%2BD1MXht1yrsL7M 10.1007/s11033-008- 9428-8 19107574
30. Y Teng H Cui M Yang H Song Q Zhang Y Su J Zheng 2009 Protective effect of puerarin on diabetic retinopathy in rats Mol Biol Rep 36 5 1129 1133 1:CAS:528:DC%2BD1MXjvFaqurg%3D 10.1007/s11033-008-9288-2 18587665
31. S Tesfaye R Malik JO Ward 1994 Vascular factors in diabetic neuropathy Diabetologia 37 847 854 1:STN:280:DyaK2M7gsVKjtg%3D%3D 10.1007/BF00400938 7806013
32. MJ Stevens EL Feldman DA Greene 1995 The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects Diabetes Med 12 566 579 1:STN:280:DyaK28%2FisVWjug%3D%3D 10.1111/j.1464-5491.1995.tb00544.x
33. P Schratzberger G Schratzberger M Silver C Curry M Kearney M Magner J Alroy LS Adelman DH Weinberg AH Ropper JM Isner 2000 Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy Nat Med 6 405 413 1:CAS:528:DC%2BD3cXisVOrurw%3D 10.1038/74664 10742147
34. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Diabetes Care 20:1183-1197
35. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin dependent diabetes mellitus N Engl J Med 329 977 986 10.1056/NEJM199309303291401
36. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6
37. XY Gao HY Kuang W Zou XM Liu HB Lin Y Yang 2009 The timing of re-institution of good blood glucose control affects apoptosis and expression of Bax and Bcl-2 in the retina of diabetic rats Mol Biol Rep 36 7 1977 1982 1:CAS:528:DC%2BD1MXptV2nu7s%3D 10.1007/s11033-008-9407-0 18991018
38. ER Seaquist FC Goetz S Rich J Barbosa 1989 Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy N Engl J Med 320 1161 1165 1:STN:280:DyaL1M3hvFWqtA%3D%3D 10.1056/NEJM198905043201801 2710189
39. The Diabetes Control and Complications Trial Research Group 1997 Clustering of long-term complications in families with diabetes in the diabetes control and complications trial Diabetes 46 1829 1839 10.2337/diabetes.46.11. 1829
40. W Renner S Kotschan C Hoffmann B Obermayer-Pietsch E Pilger 2000 A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J Vasc Res 37 443 448 1:CAS:528:DC%2BD3MXoslGmsQ%3D%3D 10.1159/000054076 11146397
41. CJ Watson NJ Webb MJ Bottomley PE Brenchley 2000 Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 1232 1235 1:CAS:528:DC%2BD3cXltlOqsbw%3D 10.1006/cyto.2000.0692 10930302
42. M Shahbazi M Fryer V Pravica IJ Brogan HM Ramsay IV Hutchinson PN Harden 2002 Vascular endothelial growth factor gene polymorph isms are associated with acute renal allograft rejection J Am Soc Nephrol 13 260 264 1:CAS:528: DC%2BD38XltV2ntg%3D%3D 11752046
43. T Wang K Hu J Ren Q Zhu G Wu G Peng 2010 Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population Mol Biol Rep 37 1 59 65 1:CAS:528:DC%2BC3cXisFSmtg%3D%3D 10.1007/s11033-009-9526-2 19340604
44. IH Onen E Konac M Eroglu C Guneri H Biri A Ekmekci 2008 No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population Mol Biol Rep 35 1 17 22 1:CAS:528:DC%2BD1cXhtFahur4%3D 10.1007/s11033-006-9046-2 17216542
45. S Sfar H Saad F Mosbah L Chouchane 2009 Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness Mol Biol Rep 36 1 37 45 1:CAS:528:DC%2BD1cXhtl2mu7rO 10.1007/s11033-007-9149-4 17917789
46. S Marsh FM Nakhoul K Skorecki A Rubin BP Miller R Leibu NS Levy AP Levy 2000 Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy Diabetes Care 23 1375 1380 1:STN:280:DC%2BD3M%2Fls1Smsw%3D%3D 10.2337/diacare.23.9.1375 10977036
47. N Chaturvedi JH Fuller F Pokras R Rottiers N Papazoglou LP Aiello EUCLID Study Group 2001 Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition Diabet Med 18 288 294 1:CAS:528:DC%2BD3MXltFWrt7c%3D 10.1046/j.1464-5491.2001.00441.x 11437859